NCT00230516View on ClinicalTrials.gov

Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

February 28, 2006

Conditions
Healthy
Interventions
DRUG

Nexium

DRUG

Prevacid

Trial Locations (2)

Unknown

Research Site, Los Angeles

Research Site, Oklahoma City

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00230516 - Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects | Biotech Hunter | Biotech Hunter